Clinical Trial Setback Sends Intellia Shares Plummeting
Intellia Therapeutics faced a severe market downturn following the disclosure of a patient death in a pivotal Phase 3 clinical...
Accomplished economist, entrepreneur, and profound expert in financial markets.
Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.
Intellia Therapeutics faced a severe market downturn following the disclosure of a patient death in a pivotal Phase 3 clinical...
Xiaomi finds itself in the crosshairs of institutional investors, with a notable surge in bearish sentiment gripping the market. As...
Ocugen's latest quarterly earnings report has triggered alarm bells across the investment community. The clinical-stage biopharmaceutical company reported a significantly...
A powerful combination of bullish analyst sentiment and record-breaking commodity prices is creating exceptional momentum for Almonty Industries. The Canadian...
Investors expressed reservations about ASML Holding NV's position in China, sending shares lower despite the semiconductor equipment maker's public commitment...
In a surprising market development, Palantir Technologies Inc. finds itself facing substantial selling pressure even as the company reports extraordinary...
The gold mining industry is abuzz with speculation as rumors circulate about a potential multi-billion dollar transaction between industry titans...
Micron Technology's stock experienced a dramatic surge, climbing nearly 9% during Thursday's trading session to establish a fresh record high...
Nature's Sunshine Products has delivered a spectacular earnings surprise for the third quarter of 2025, shattering analyst projections with exceptional...
A coordinated bearish assault is unfolding against Chinese technology giant Xiaomi, with hedge funds dramatically increasing their short positions just...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com